New device aims to curb dangerous bleeding in heart surgery patients on blood thinners
NCT ID NCT07284199
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study tests a device called CA330 that is used during heart surgery to filter the blood. The goal is to see if it can lower the risk of severe bleeding in patients who take blood thinners and need emergency heart surgery. About 120 adults will be randomly assigned to receive either the CA330 device or standard care. Researchers will track bleeding events, blood transfusions, and recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CABG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Center for Cardiac Intensive Care, Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100029, China
Conditions
Explore the condition pages connected to this study.